BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19591630)

  • 1. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
    Nakagomi T; Nakagomi O
    Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccines.
    Vesikari T
    Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis.
    McCormack PL; Keam SJ
    Paediatr Drugs; 2009; 11(1):75-88. PubMed ID: 19127963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.
    ;
    Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical time for rotavirus vaccines: a review.
    Cunliffe NA; Nakagomi O
    Expert Rev Vaccines; 2005 Aug; 4(4):521-32. PubMed ID: 16117709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotarix (RIX4414): an oral human rotavirus vaccine.
    O'Ryan M
    Expert Rev Vaccines; 2007 Feb; 6(1):11-9. PubMed ID: 17280473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
    Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
    Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotarix: a rotavirus vaccine for the world.
    Ward RL; Bernstein DI
    Clin Infect Dis; 2009 Jan; 48(2):222-8. PubMed ID: 19072246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccine RIX4414 (Rotarix).
    Keating GM
    Paediatr Drugs; 2006; 8(6):389-95; discussion 396-7. PubMed ID: 17154645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.